Stock News
Unleashing the Power of CervoMed: Join Us for an Exciting Oral Presentation at the 8th International Lewy Body Dementia Conference!
CervoMed Inc. Announces Presentation of RewinD-LB Phase 2b Study Data at ILBDC Conference Topline Data Expected in December 2024 BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company specializing in treatments for age-related neurologic disorders, has disclosed that they will be sharing detailed safety and efficacy results from the completed…
Mark your calendars! BrainsWay’s Third Quarter 2024 Financial Results are coming on November 12, 2024 – get ready to geek out with us!
Welcome to the latest news in mental health technology! Exciting Updates from BrainsWay Ltd. BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter…
Inverite Reaches New Milestone with Mortgage Automator: Over 200 Private Lenders and Mortgage Investment Corporations Now on Proprietary Open Banking Platform
Inverite Insights Inc. Reports Rapid Adoption of Open Banking Platform Vancouver, British Columbia–(Newsfile Corp. – October 29, 2024) – Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRF) (FSE: 2V00) (“Inverite” or the “Company”), a leading AI-driven software provider utilizing real-time financial data to empower credit facilitators to transact more effectively with consumers is excited to…
Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart in Type 1 Diabetes Patients Undergoing Islet Transplantation
Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart Breakthrough in Type 1 Diabetes Patients Undergoing Islet Transplantation Diabetes has been a prevalent health issue affecting millions of people worldwide, with Type 1 Diabetes (T1D) being a particularly challenging condition to manage. However, a recent development by Eledon Pharmaceuticals has sparked hope and excitement…
Uncovering the Truth: Light Wonder Inc. Under Investigation for Possible Securities Law Violations – Reach Out to Levi Korsinsky for More Information – LNw
The Impact of the Light & Wonder Investigation Introduction Recently, Levi & Korsinsky announced an investigation into Light & Wonder, Inc. to determine if there have been any violations of federal securities laws. This investigation comes on the heels of a lawsuit filed by Aristocrat Technologies against Light & Wonder, Inc. in February of 2024….
Breaking Barriers: Beyond Oil Makes Strides in Eastern Europe with 16-Ton Order from Franchisee of Popular Fast Food Chain
Order Represents Major Milestone in Advancing Beyond Oil’s Global Expansion Embracing a Healthier Future With the rising concerns over health risks associated with fried foods, the innovative strides taken by Beyond Oil Ltd. are nothing short of groundbreaking. By focusing on reducing these risks, the company is not only revolutionizing the food-tech industry but also…
Plus Therapeutics Presents Leptomeningeal Metastases Programs at 2024 SNO Annual Meeting in Houston, Texas
Company to Present Results from Phase 1 Clinical Trial of Rhenium (186Re) Obisbemeda for Leptomeningeal Metastases AUSTIN, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for CNS cancers, will be presenting data at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting in Houston, Texas….
Attention SIGA Shareholders and Investors: Important Update on SIGA Technologies Inc. Investigation – Contact Levi & Korsinsky for Assistance
Investigation Commenced for SIGA Technologies, Inc. Violations New York, NY / ACCESSWIRE / October 29, 2024 / Levi & Korsinsky Investigation Details Levi & Korsinsky has recently announced that an investigation has been initiated regarding SIGA Technologies, Inc. The investigation focuses on potential violations of federal securities laws by SIGA Technologies, Inc. (NASDAQ:SIGA). The probe…